Lipid Injectable Market

Global Lipid Injectable Market – Overview

Lipid injectable has been used as source of energy that offers the necessary vitamins and fatty acids to the hospitalized patients. Currently, lipid emulsions are mainly used for providing intravenous lipid soluble therapeutic agents. This is because of the biocompatible nature of these lipid-based delivery systems. The global lipid injectable market is expected to achieve a stellar growth in the coming few years of the forecast period.

Global Lipid Injectable Market – Notable Developments

The competitive landscape of the global lipid injectable market is fragmented one with the presence of several key players. One of the primary focus for these leading companies is development of new products. With investments and funding from both private and public sector, there has been a growing onus on product development.

Some of the recent developments in the global lipid injectable market are given below:

• In March 2019, Baxter International Inc., while presenting at the 2019 ASPEN Nutrition Science & Practice Conference, announced that the company will be launching Clinolipid, a lipid injectable emulsion with 20% base of olive oil, in the US market by, the fall of 2019. The company is targeting to tackle the growing problem of malnutrition in the region. 

Global Lipid Injectable Market – Drivers and Restraints

There are several factors that are helping to push the growth of the global lipid injectable market. One of the key driving factor for the market growth has been launch of several new lipid injectable products to meet the growing demand across the globe. Some of the key reasons behind the increasing demand has been the growing incidences of malnutrition, weakening of immune system, physiological degradation, and chronic illness among others.

Another important factor that is helping to drive the growth of the global lipid injectable market has been the increasing investments for the activities of research and development. More and more pharmaceutical companies are putting in money to develop advanced lipid injectable products to cater to the growing demand. In addition to this, the governments across the globe are also providing funding and easy approvals to bring such new products in the market. This too has helped the growth of the market.

Global Lipid Injectable Market – Geographical Outlook

The global lipid injectable market is segmented into five key regions to give a better understanding of its geographical segmentation. The regions are North America, Latin America, Europe, Middle East and Africa, and Asia Pacific. Of these regional segments, currently, the global lipid injectable market is dominated by the North America region. The regional segment of Europe is next in line after North America. The growth of the North America market for lipid injectable can be primarily attributed to the growing introduction of new and innovative products that are approved by the US Food and Drug Administration (FDA). Europe too is projected to show a steady growth rate in coming years as there is growing awareness about the benefits of using lipid injectable drugs.

On the other hand, the regional segment of Asia Pacific is expected show a promising rate of growth in the coming years of the forecast period of 2019 to 2027. The growth of the regional segment is mainly down to the increasing incidences of accidents and cases of critical illness that are then followed several changes in the body such as impaired immune system, malnutrition, intense metabolic changes, and physiological degradation among others. Moreover, growing investments from governments of emerging economies such as India and China for the development of the domestic medical and healthcare infrastructure is also expected to drive the growth of the lipid injectable market in Asia Pacific.